Trinity Biotech (NASDAQ:TRIB) Cut to Sell at StockNews.com
StockNews.com cut shares of Trinity Biotech (NASDAQ:TRIB – Free Report) from a hold rating to a sell rating in a research report released on Thursday. Trinity Biotech Stock Up 1.6 % Shares of TRIB ...
ETF Daily News26d
Trinity Biotech (NASDAQ:TRIB) Earns Hold Rating from Analysts at StockNews.com
Trinity Biotech has a twelve month low of $0.74 and ... sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis ...
Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process
With substantial progress in developing its differentiated and innovative CGM and its significant market potential, Trinity Biotech’s board and management have determined that CGM technology and ...